Track this trial free. DataLookout checks ClinicalTrials.gov daily and emails you which fields changed on NCT07613099 (status, enrollment, completion dates, endpoints, sites) when this record is updated. Free accounts track up to 5 trials.

Track this trial

Fibrotic Disease Activity in Cardiopulmonary Disorders Using 18F-Fibroblast Activation Protein Inhibitor (18F-FAPI-74) PET/CT Imaging

StatusRecruiting
PhasePhase 3
Started
View on ClinicalTrials.gov ↗

Record History

The 50 most recent of 81 record versions are listed below. See every version on ClinicalTrials.gov ↗

  1. Minor Re-verified, no change to tracked fields
  2. Minor Start date changed from estimate of Sep 27, 2026 to Sep 18, 2026
  3. Minor Start date: Sep 24, 2026 to Sep 27, 2026
  4. Minor Start date: Sep 23, 2026 to Sep 24, 2026
  5. Minor Start date: Sep 22, 2026 to Sep 23, 2026
Show 43 earlier versionsHide 43 earlier versions
  1. Minor Start date: Sep 20, 2026 to Sep 22, 2026
    • Interventions: 18F-FAPI-74 PET/CT Imaging (Diagnostic Test), [18F]FAPI-74 (Drug) to 18F-FAPI-74 PET/CT Imaging (Diagnostic Test), [18F]FAPI-74 (Drug)
  2. Minor Start date: Sep 17, 2026 to Sep 20, 2026v75
  3. Minor Start date: Sep 16, 2026 to Sep 17, 2026v74
  4. Minor Start date: Sep 15, 2026 to Sep 16, 2026v73
  5. Minor Start date: Sep 14, 2026 to Sep 15, 2026v72
  6. Minor Start date: Sep 10, 2026 to Sep 14, 2026v71
  7. Minor Start date: Sep 9, 2026 to Sep 10, 2026v70
  8. Minor Start date: Sep 8, 2026 to Sep 9, 2026v69
  9. Minor Start date: Sep 7, 2026 to Sep 8, 2026v68
  10. Minor Start date: Sep 6, 2026 to Sep 7, 2026v67
  11. Minor Start date: Sep 3, 2026 to Sep 6, 2026v66
  12. Minor Start date: Sep 2, 2026 to Sep 3, 2026v65
  13. Minor Start date: Sep 1, 2026 to Sep 2, 2026v64
  14. Minor Start date: Aug 31, 2026 to Sep 1, 2026v63
  15. Minor Start date: Aug 30, 2026 to Aug 31, 2026v62
  16. Minor Start date: Aug 27, 2026 to Aug 30, 2026v61
  17. Minor Start date: Aug 26, 2026 to Aug 27, 2026v60
  18. Minor Start date: Aug 25, 2026 to Aug 26, 2026v59
  19. Minor Start date: Aug 24, 2026 to Aug 25, 2026v58
  20. Minor Start date: Aug 23, 2026 to Aug 24, 2026v57
  21. Minor Start date: Aug 20, 2026 to Aug 23, 2026v56
  22. Minor Start date: Aug 19, 2026 to Aug 20, 2026v55
  23. Minor Start date: Aug 18, 2026 to Aug 19, 2026v54
  24. Minor Start date: Aug 17, 2026 to Aug 18, 2026v53
  25. Minor Start date: Aug 16, 2026 to Aug 17, 2026v52
  26. Minor Start date: Aug 13, 2026 to Aug 16, 2026v51
  27. Minor Start date: Aug 12, 2026 to Aug 13, 2026v50
  28. Minor Start date: Aug 11, 2026 to Aug 12, 2026v49
  29. Minor Start date: Aug 10, 2026 to Aug 11, 2026v48
  30. Minor Start date: Aug 7, 2026 to Aug 10, 2026v47
  31. Minor Start date: Aug 6, 2026 to Aug 7, 2026v46
  32. Minor Start date: Aug 5, 2026 to Aug 6, 2026v45
  33. Minor Start date: Aug 4, 2026 to Aug 5, 2026v44
  34. Minor Start date: Aug 3, 2026 to Aug 4, 2026v43
  35. Minor Start date: Aug 2, 2026 to Aug 3, 2026v42
  36. Minor Start date: Jul 30, 2026 to Aug 2, 2026v41
  37. Minor Start date: Jul 29, 2026 to Jul 30, 2026v40
  38. Minor Start date: Jul 28, 2026 to Jul 29, 2026v39
  39. Minor Start date: Jul 27, 2026 to Jul 28, 2026v38
  40. Minor Start date: Jul 26, 2026 to Jul 27, 2026v37
  41. Minor Start date: Jul 23, 2026 to Jul 26, 2026v36
  42. Minor Start date: Jul 22, 2026 to Jul 23, 2026v35
  43. Minor Start date: Jul 21, 2026 to Jul 22, 2026v34
  1. Notable Recruitment opened
    • Start date: Jul 20, 2026 to Jul 21, 2026
    v33
  2. Minor Start date: Jul 19, 2026 to Jul 20, 2026v32
  • Stopped: an ongoing trial was terminated, suspended or withdrawn.
  • Notable: the trial’s plan changed such as a big move in its timeline or size, a new primary endpoint, sponsor or phase, or recruiting opened or resumed.
  • Minor: routine progress and housekeeping, such as sites added or enrollment closed.
Background: Injury or diseases of the heart and lung can sometimes cause scar tissue (fibrosis) to build up in those organs. Current imaging scans can see this scar tissue once it has formed, but researchers want to find a way to detect the fibrosis in its earliest stages, while there might still be time to prevent serious damage. A new tracer (a radioactive substance injected during imaging scans) may be able to help. Objective: To test a new tracer (18F-FAPI-74) during imaging scans in people with heart or lung disease. Eligibility: People aged 18 years and older with lung or heart disease that may cause scarring in those organs. Design: Participants will have 6 clinic visits over 2 years. Participants will be screened: They will have blood tests and tests of their heart and lung function. Those with heart disease will have a magnetic resonance imaging (MRI) scan of the heart. The study tracer will be used with positron emission tomography (PET)/computed tomography (CT) scans. The study tracer will be injected into a vein in the arm. Participants will lie on a padded bed that slides through a donut-shaped machine. Participants will have scans with the study tracer 2 times, 8 to 12 months apart. They will also have standard CT scans and blood tests during these visits. They will also have blood tests at 3 and 6 months between these visits. Participants will have a follow-up visit after 18 to 24 months. The study scans, MRI and standard CT scans, and lung function tests may be repeated....
Trial Details
NCT Number NCT07613099
Lead Sponsor National Heart, Lung, and Blood Institute (NHLBI)
Conditions
(from sponsor)
Allogeneic Stem Cell Transplantation, Lung Allograft Transplantation, Interstitial Lung Disease, Acute Lung Injury, Pulmonary Arterial Hypertension, Cardiovascular Diseases
Related terms Acute Lung Injury, Cardiovascular Diseases, Lung Diseases, Interstitial, Pulmonary Arterial Hypertension
Enrollment 210 participants
Start Date
Primary Completion (estimated)
Study Completion (estimated)
Updated on ClinicalTrials.gov